Skip to content

Tag Archives: New Drugs

Quizartinib: Surprising, Unprecedented Activity in Relapsed AML


ATLANTA, Georgia — The investigational agent quizartinib (Astellas/Ambit) has shown unprecedented activity in patients with relapsed and refractory acute myeloid leukemia (AML) in a phase 2 clinical trial. On the basis of these results, larger phase 3 clinical trials with the drug are being planned, according to Astellas/Ambit. Patients with AML can develop many different […]

The new anti-diabetes drug GLP-1 receptor agonists


This article comes from references available on internet. It is about a new drug called Glucagon-like Peptide-1 [GLP-1] Receptor Agonists. So GLP-1R Agonists is analog of human glucagon-like peptide-1, and it acts as GLP-1 receptor agonist to increase insulin secretion in the presence of elevated blood glucose. Also it delays gastric emptying to decrease postprandial glucose and decreases […]

Guideline discusses oral pharmacotherapy for Type 2 diabetes


In this article the author disscuss several oral anti-diabetes drugs, including: Metformin Sulfonylureas Meglitinides Thiazolidinediones Dipeptidyl Peptidase-4 [DPP-4] inhibitors Glucagon-like Peptide-1 [GLP-1] Receptor Antagonists Note: According relative references I think Medscape have made a mistake. It should be Agonists instead of Antagonists. I reviewed my pharmacology textbooks (a very old version) and found there were only four types […]